SIRT1 and digestive system neoplasm: To gain further insight into the presence of SIRT1 in gastrointestinal tumors, this study examined the distribution of SIRT1 in gastric cancer (GC), colon cancer (CC), and rectal cancer (RC) tissues and normal tissues, as well as in plasma of patients with gastric, colon, and rectal cancers and healthy populations.